Pediatric injuries in Central Texas

Texas Medicine
|September 3, 2009
PubMed

Insights

In Texas, pediatric injury deaths, primarily from falls and motor vehicle collisions (MVCs), significantly exceed other causes. Most child MVC injuries and fatalities involved unrestrained children, highlighting critical prevention needs.

Area of Science:

  • Public Health
  • Pediatric Trauma
  • Injury Prevention

Background:

  • In Texas, injury is the leading cause of death for children aged 1-14, surpassing the next nine causes combined.
  • Pediatric injuries in Central Texas during 2003-2004 were predominantly caused by falls and motor vehicle collisions (MVCs).

Purpose of the Study:

  • To analyze injury data for children hospitalized and deceased in Central Texas from 2003-2004.
  • To identify primary causes of pediatric injury and death to inform prevention strategies.

Main Methods:

  • Data were extracted from the Public Use Data File maintained by the Injury and EMS/Trauma Registry Group.
  • Analysis focused on injury types, causes, restraint use in MVCs, and mortality outcomes for hospitalized children.

Main Results:

  • Falls and MVCs were the leading causes of hospitalization for injured children.
  • During 2003-2004, 175 children died from injury-related events, with 56 deaths occurring post-hospitalization.
  • Traumatic brain injury was the most common cause of fatal injury, and most children in MVCs were not restrained.

Conclusions:

  • Injury prevention efforts in Texas must prioritize addressing falls and MVCs in children.
  • The high incidence of unrestrained children in MVCs underscores the need for improved safety measures and enforcement.
  • Utilizing injury data is crucial for developing targeted and effective public health interventions to reduce child mortality and morbidity.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...